한글목차

면역학 시장

2023년 면역학 시장 규모는 1,101억 달러로 평가되었고, 2024-2033년간 6.3%의 연평균 복합 성장률(CAGR)로 2033년에는 2,040억 달러에 달할 것으로 예측됩니다.

면역학은 생물의 면역체계를 연구하는 과학의 한 분야입니다. 면역계는 감염, 이물질, 질병과 싸우는 생체의 방어 메커니즘입니다. 면역학은 종양학, 장기이식, 류마티스학, 세균학, 바이러스학, 기생충학, 피부과학, 정신의학 등 다양한 의학 분야에 응용되고 있습니다.

면역학 시장을 주도하는 것은 면역 질환의 유병률 증가와 이러한 질환의 치료에 대한 개인의 인식이 높아지고 있기 때문입니다. 또한, 전 세계 각국 정부가 과학 및 의료 분야에 대한 지출을 늘리고 있는 것도 면역학 시장의 성장을 가속하고 있습니다. 바이오시밀러와 개인맞춤형 의료의 발전은 현재 시장에 새로운 전망을 가져오고 있습니다. 또한, 환자의 면역 프로파일이 치료의 지침이 되어 치료와 투약의 효과를 높일 수 있는 개인맞춤형 면역치료는 향후 주류가 될 것으로 예상됩니다.

그러나 면역학에서 신약개발은 장기간에 걸친 과정으로, 연구실에서 10-15년이 소요되는 경우가 많아 시장 성장에 걸림돌로 작용하고 있습니다. 또한, 신약 및 치료법에 대한 엄격한 규정 준수 요건과 승인 절차가 길어지는 것도 시장 성장에 큰 걸림돌로 작용하고 있습니다. 예를 들어, 미국 식품의약국(FDA)은 의약품을 출시하기 전에 준수해야 하는 일련의 긴 규제를 시행하고 있습니다. 이 일련의 규제에는 전임상시험, 임상시험 신청, 3단계 임상시험, 신약 승인 신청, 그리고 시판 후 조사까지 포함됩니다. 의약품 제조업체는 의약품의 효능과 장기적인 효과를 보장하기 위해 이 일련의 과정을 따라야 합니다.

부문별 리뷰

면역학 시장은 제품 유형, 용도, 최종 사용자, 지역으로 분류됩니다. 제품 유형별로는 진단검사기기, 바이오마커, 바이오의약품으로 분류됩니다. 용도별로는 알레르기 및 과민증, 자가면역질환, 감염성 질환, HIV 및 에이즈, 기타로 분류됩니다. 최종사용자별로는 병원 및 클리닉, 제약 및 생명공학 기업, 진단 실험실, 기타로 분류됩니다. 지역별로는 북미, 유럽, 아시아태평양, LAMEA로 분석됩니다.

주요 조사 결과

제품 유형별로는 바이오 의약품 분야가 예측 기간 동안 우위를 유지할 것으로 예상됩니다.

용도별로는 자가면역질환 분야가 2033년까지 높은 시장 점유율을 차지할 것으로 예상됩니다.

최종 사용자별로는 병원 및 클리닉 분야가 예측 기간 동안 가장 높은 점유율을 차지할 것으로 예상됩니다.

지역별로는 북미가 2033년까지 우위를 유지할 것으로 예측됩니다.

이 보고서는 사용자 정의가 가능합니다.

• 규제 가이드라인
• 고객의 관심사에 따른 기업 프로파일 추가
• 국가별 또는 지역별 추가 분석 - 시장 규모 및 전망
• 기업 프로파일 확장 목록
• 과거 시장 데이터
• 주요 기업의 세부 정보(위치, 연락처, 공급업체/벤더 네트워크 등 포함, 엑셀 형식)

목차

제1장 서론

제2장 주요 요약

제3장 시장 구도

• 시장 정의와 범위
• 주요 조사 결과
  • 주요 투자 기회
  • 주요 성공 전략
• Porter의 Five Forces 분석
• 시장 역학
  • 성장 촉진요인
  • 성장 억제요인
  • 기회

제4장 면역학 시장 : 제품 유형별

• 시장 개요
• 진단 검사기기
• 바이오마커
• 바이오의약품

제5장 면역학 시장 : 용도별

• 시장 개요
• 알레르기 및 과민증
• 자가면역질환
• 감염증
• HIV 및 에이즈
• 기타

제6장 면역학 시장 : 최종사용자별

• 시장 개요
• 병원 및 클리닉
• 제약 기업 및 바이오테크놀러지 기업
• 진단 실험실
• 기타

제7장 면역학 시장 : 지역별

• 시장 개요
• 북미
  • 주요 시장 동향과 기회
  • 미국 면역학 시장
  • 캐나다 면역학 시장
  • 멕시코 면역학 시장
• 유럽
  • 주요 시장 동향과 기회
  • 독일 면역학 시장
  • 프랑스 면역학 시장
  • 영국 면역학 시장
  • 이탈리아 면역학 시장
  • 스페인 면역학 시장
  • 기타 유럽 면역학 시장
• 아시아태평양
  • 주요 시장 동향과 기회
  • 일본 면역학 시장
  • 중국 면역학 시장
  • 인도 면역학 시장
  • 호주 면역학 시장
  • 한국 면역학 시장
  • 기타 아시아태평양 면역학 시장
• 라틴아메리카/중동 및 아프리카
  • 주요 시장 동향과 기회
  • 브라질 면역학 시장
  • 사우디아라비아 면역학 시장
  • 남아프리카공화국 면역학 시장
  • 기타 라틴아메리카/중동 및 아프리카 면역학 시장

제8장 경쟁 구도

• 서론
• 주요 성공 전략
• 주요 10개 기업의 제품 매핑
• 경쟁 대시보드
• 경쟁 히트맵
• 주요 기업의 포지셔닝(2023년)

제9장 기업 개요

• AbbVie Inc.
• Johnson And Johnson
• Pfizer Inc.
• Novartis AG
• Merck And Co., Inc.
• Bristol-Myers Squibb Company
• Amgen Inc.
• Eli Lilly And Company
• Gilead Sciences, Inc.
• Sanofi

영문목차

Immunology Market

The immunology market was valued at $110.1 billion in 2023 and is projected to reach $204.0 billion by 2033, growing at a CAGR of 6.3% from 2024 to 2033.

Immunology is a branch of science involved in studying the immune system of an organism. Immune system is the defense mechanism of a living body which fights against infections, foreign substances, and diseases. Immunology finds applications in diverse disciplines of medicine, including oncology, organ transplantation, rheumatology, bacteriology, virology, parasitology, dermatology, and psychiatry.

The immunology market is driven by rise in prevalence of immunological diseases and surge in awareness among individuals regarding the treatment of such diseases. In addition, governments across the globe have increased their expenditure in the field of science and medicine, thereby augmenting the growth of the immunology market. Boost in the trend of biosimilars and personalized medicine is currently presenting new prospects for the market. Moreover, personalized immunotherapy is projected to become mainstream in the future as a patient's immune profile guides the treatment in this approach, hence elevating the effectiveness of the therapy and medications.

However, drug discovery is a lengthy process in immunology, which often requires 10-15 years of research in the laboratory, hence hampering the market growth. In addition, the stringent compliance requirements and the extended approval procedure of new drugs & treatments is a significant restraint for the market. For instance, the U.S. Food and Drug Administration has implemented a long series of regulations which is necessary to follow before releasing any drug in the market. This series involves preclinical testing, submission of investigational new drug application, three phases of clinical trials, submission of new drug application, and lastly post-market surveillance. Drug manufacturers are obliged to follow the sequence to ensure the efficacy and long-term effects of their medications.

Segment Review

The immunology market is segmented into product type, application, end user, and region. On the basis of product type, the market is divided into diagnostic testing equipment, biomarkers, and biopharmaceuticals. By application, it is classified into allergy & hypersensitivity, autoimmune disease, infectious disease, HIV & AIDS, and others. As per end user, it is categorized into hospitals & clinics, pharmaceutical & biotechnology companies, diagnostic laboratories, and others. Region wise, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

Key Findings

On the basis of product type, the biopharmaceuticals segment is expected to maintain its dominance during the forecast period.

By application, the autoimmune disease segment is projected to garner a high market share by 2033.

As per end user, the hospitals & clinics segment is anticipated to be the highest shareholder during the forecast period.

Region wise, North America is predicted to maintain its dominance by 2033.

Competition Analysis

The major players operating in the global immunology market include AbbVie Inc., Johnson & Johnson, Pfizer Inc., Novartis AG, Merck & Co., Inc., Bristol-Myers Squibb Company, Amgen Inc., Eli Lilly and Company, Gilead Sciences, Inc., and Sanofi. These players have adopted various key developmental strategies such as business expansion, new product launches, and partnerships to strengthen their foothold in the market.

Additional benefits you will get with this purchase are:

• Quarterly Update and* (only available with a corporate license, on listed price)
• 5 additional Company Profile of client Choice pre- or Post-purchase, as a free update.
• Free Upcoming Version on the Purchase of Five and Enterprise User License.
• 16 analyst hours of support* (post-purchase, if you find additional data requirements upon review of the report, you may receive support amounting to 16 analyst hours to solve questions, and post-sale queries)
• 15% Free Customization* (in case the scope or segment of the report does not match your requirements, 15% is equivalent to 3 working days of free work, applicable once)
• Free data Pack on the Five and Enterprise User License. (Excel version of the report)
• Free Updated report if the report is 6-12 months old or older.
• 24-hour priority response*
• Free Industry updates and white papers.

Possible Customization with this report (with additional cost and timeline, please talk to the sales executive to know more)

• Regulatory Guidelines
• Additional company profiles with specific to client's interest
• Additional country or region analysis- market size and forecast
• Expanded list for Company Profiles
• Historic market data
• Key player details (including location, contact details, supplier/vendor network etc. in excel format)

Key Market Segments

By Product Type

• Diagnostic Testing Equipment
• Biomarkers
• Biopharmaceuticals

By Application

• Allergy and Hypersensitivity
• Autoimmune Disease
• Infectious Disease
• HIV and AIDS
• Others

By End User

• Hospitals and Clinics
• Pharmaceutical and Biotechnology Companies
• Diagnostic Laboratories
• Others

By Region

• North America
  • U.S.
  • Canada
  • Mexico
• Europe
  • Germany
  • France
  • UK
  • Italy
  • Spain
  • Rest of Europe
• Asia-Pacific
  • Japan
  • China
  • India
  • Australia
  • South Korea
  • Rest of Asia-Pacific
• LAMEA
  • Brazil
  • Saudi Arabia
  • South Africa
  • Rest of LAMEA

Key Market Players:

• AbbVie Inc.
• Johnson & Johnson
• Pfizer Inc.
• Novartis AG
• Merck & Co., Inc.
• Bristol-Myers Squibb Company
• Amgen Inc.
• Eli Lilly and Company
• Gilead Sciences, Inc.
• Sanofi

TABLE OF CONTENTS

CHAPTER 1: INTRODUCTION

• 1.1. Report Description
• 1.2. Key Market Segments
• 1.3. Key Benefits
• 1.4. Research Methodology
  • 1.4.1. Primary Research
  • 1.4.2. Secondary Research
  • 1.4.3. Analyst Tools and Models

CHAPTER 2: EXECUTIVE SUMMARY

• 2.1. CXO Perspective

CHAPTER 3: MARKET LANDSCAPE

• 3.1. Market Definition and Scope
• 3.2. Key Findings
  • 3.2.1. Top Investment Pockets
  • 3.2.2. Top Winning Strategies
• 3.3. Porter's Five Forces Analysis
  • 3.3.1. Bargaining Power of Suppliers
  • 3.3.2. Threat of New Entrants
  • 3.3.3. Threat of Substitutes
  • 3.3.4. Competitive Rivalry
  • 3.3.5. Bargaining Power among Buyers
• 3.5. Market Dynamics
  • 3.5.1. Drivers
  • 3.5.2. Restraints
  • 3.5.3. Opportunities

CHAPTER 4: IMMUNOLOGY MARKET, BY PRODUCT TYPE

• 4.1. Market Overview
  • 4.1.1 Market Size and Forecast, By Product Type
• 4.2. Diagnostic Testing Equipment
  • 4.2.1. Key Market Trends, Growth Factors and Opportunities
  • 4.2.2. Market Size and Forecast, By Region
  • 4.2.3. Market Share Analysis, By Country
• 4.3. Biomarkers
  • 4.3.1. Key Market Trends, Growth Factors and Opportunities
  • 4.3.2. Market Size and Forecast, By Region
  • 4.3.3. Market Share Analysis, By Country
• 4.4. Biopharmaceuticals
  • 4.4.1. Key Market Trends, Growth Factors and Opportunities
  • 4.4.2. Market Size and Forecast, By Region
  • 4.4.3. Market Share Analysis, By Country

CHAPTER 5: IMMUNOLOGY MARKET, BY APPLICATION

• 5.1. Market Overview
  • 5.1.1 Market Size and Forecast, By Application
• 5.2. Allergy And Hypersensitivity
  • 5.2.1. Key Market Trends, Growth Factors and Opportunities
  • 5.2.2. Market Size and Forecast, By Region
  • 5.2.3. Market Share Analysis, By Country
• 5.3. Autoimmune Disease
  • 5.3.1. Key Market Trends, Growth Factors and Opportunities
  • 5.3.2. Market Size and Forecast, By Region
  • 5.3.3. Market Share Analysis, By Country
• 5.4. Infectious Disease
  • 5.4.1. Key Market Trends, Growth Factors and Opportunities
  • 5.4.2. Market Size and Forecast, By Region
  • 5.4.3. Market Share Analysis, By Country
• 5.5. HIV And AIDS
  • 5.5.1. Key Market Trends, Growth Factors and Opportunities
  • 5.5.2. Market Size and Forecast, By Region
  • 5.5.3. Market Share Analysis, By Country
• 5.6. Others
  • 5.6.1. Key Market Trends, Growth Factors and Opportunities
  • 5.6.2. Market Size and Forecast, By Region
  • 5.6.3. Market Share Analysis, By Country

CHAPTER 6: IMMUNOLOGY MARKET, BY END USER

• 6.1. Market Overview
  • 6.1.1 Market Size and Forecast, By End User
• 6.2. Hospitals And Clinics
  • 6.2.1. Key Market Trends, Growth Factors and Opportunities
  • 6.2.2. Market Size and Forecast, By Region
  • 6.2.3. Market Share Analysis, By Country
• 6.3. Pharmaceutical And Biotechnology Companies
  • 6.3.1. Key Market Trends, Growth Factors and Opportunities
  • 6.3.2. Market Size and Forecast, By Region
  • 6.3.3. Market Share Analysis, By Country
• 6.4. Diagnostic Laboratories
  • 6.4.1. Key Market Trends, Growth Factors and Opportunities
  • 6.4.2. Market Size and Forecast, By Region
  • 6.4.3. Market Share Analysis, By Country
• 6.5. Others
  • 6.5.1. Key Market Trends, Growth Factors and Opportunities
  • 6.5.2. Market Size and Forecast, By Region
  • 6.5.3. Market Share Analysis, By Country

CHAPTER 7: IMMUNOLOGY MARKET, BY REGION

• 7.1. Market Overview
  • 7.1.1 Market Size and Forecast, By Region
• 7.2. North America
  • 7.2.1. Key Market Trends and Opportunities
  • 7.2.2. Market Size and Forecast, By Product Type
  • 7.2.3. Market Size and Forecast, By Application
  • 7.2.4. Market Size and Forecast, By End User
  • 7.2.5. Market Size and Forecast, By Country
  • 7.2.6. U.S. Immunology Market
    • 7.2.6.1. Market Size and Forecast, By Product Type
    • 7.2.6.2. Market Size and Forecast, By Application
    • 7.2.6.3. Market Size and Forecast, By End User
  • 7.2.7. Canada Immunology Market
    • 7.2.7.1. Market Size and Forecast, By Product Type
    • 7.2.7.2. Market Size and Forecast, By Application
    • 7.2.7.3. Market Size and Forecast, By End User
  • 7.2.8. Mexico Immunology Market
    • 7.2.8.1. Market Size and Forecast, By Product Type
    • 7.2.8.2. Market Size and Forecast, By Application
    • 7.2.8.3. Market Size and Forecast, By End User
• 7.3. Europe
  • 7.3.1. Key Market Trends and Opportunities
  • 7.3.2. Market Size and Forecast, By Product Type
  • 7.3.3. Market Size and Forecast, By Application
  • 7.3.4. Market Size and Forecast, By End User
  • 7.3.5. Market Size and Forecast, By Country
  • 7.3.6. Germany Immunology Market
    • 7.3.6.1. Market Size and Forecast, By Product Type
    • 7.3.6.2. Market Size and Forecast, By Application
    • 7.3.6.3. Market Size and Forecast, By End User
  • 7.3.7. France Immunology Market
    • 7.3.7.1. Market Size and Forecast, By Product Type
    • 7.3.7.2. Market Size and Forecast, By Application
    • 7.3.7.3. Market Size and Forecast, By End User
  • 7.3.8. UK Immunology Market
    • 7.3.8.1. Market Size and Forecast, By Product Type
    • 7.3.8.2. Market Size and Forecast, By Application
    • 7.3.8.3. Market Size and Forecast, By End User
  • 7.3.9. Italy Immunology Market
    • 7.3.9.1. Market Size and Forecast, By Product Type
    • 7.3.9.2. Market Size and Forecast, By Application
    • 7.3.9.3. Market Size and Forecast, By End User
  • 7.3.10. Spain Immunology Market
    • 7.3.10.1. Market Size and Forecast, By Product Type
    • 7.3.10.2. Market Size and Forecast, By Application
    • 7.3.10.3. Market Size and Forecast, By End User
  • 7.3.11. Rest of Europe Immunology Market
    • 7.3.11.1. Market Size and Forecast, By Product Type
    • 7.3.11.2. Market Size and Forecast, By Application
    • 7.3.11.3. Market Size and Forecast, By End User
• 7.4. Asia-Pacific
  • 7.4.1. Key Market Trends and Opportunities
  • 7.4.2. Market Size and Forecast, By Product Type
  • 7.4.3. Market Size and Forecast, By Application
  • 7.4.4. Market Size and Forecast, By End User
  • 7.4.5. Market Size and Forecast, By Country
  • 7.4.6. Japan Immunology Market
    • 7.4.6.1. Market Size and Forecast, By Product Type
    • 7.4.6.2. Market Size and Forecast, By Application
    • 7.4.6.3. Market Size and Forecast, By End User
  • 7.4.7. China Immunology Market
    • 7.4.7.1. Market Size and Forecast, By Product Type
    • 7.4.7.2. Market Size and Forecast, By Application
    • 7.4.7.3. Market Size and Forecast, By End User
  • 7.4.8. India Immunology Market
    • 7.4.8.1. Market Size and Forecast, By Product Type
    • 7.4.8.2. Market Size and Forecast, By Application
    • 7.4.8.3. Market Size and Forecast, By End User
  • 7.4.9. Australia Immunology Market
    • 7.4.9.1. Market Size and Forecast, By Product Type
    • 7.4.9.2. Market Size and Forecast, By Application
    • 7.4.9.3. Market Size and Forecast, By End User
  • 7.4.10. South Korea Immunology Market
    • 7.4.10.1. Market Size and Forecast, By Product Type
    • 7.4.10.2. Market Size and Forecast, By Application
    • 7.4.10.3. Market Size and Forecast, By End User
  • 7.4.11. Rest of Asia-Pacific Immunology Market
    • 7.4.11.1. Market Size and Forecast, By Product Type
    • 7.4.11.2. Market Size and Forecast, By Application
    • 7.4.11.3. Market Size and Forecast, By End User
• 7.5. LAMEA
  • 7.5.1. Key Market Trends and Opportunities
  • 7.5.2. Market Size and Forecast, By Product Type
  • 7.5.3. Market Size and Forecast, By Application
  • 7.5.4. Market Size and Forecast, By End User
  • 7.5.5. Market Size and Forecast, By Country
  • 7.5.6. Brazil Immunology Market
    • 7.5.6.1. Market Size and Forecast, By Product Type
    • 7.5.6.2. Market Size and Forecast, By Application
    • 7.5.6.3. Market Size and Forecast, By End User
  • 7.5.7. Saudi Arabia Immunology Market
    • 7.5.7.1. Market Size and Forecast, By Product Type
    • 7.5.7.2. Market Size and Forecast, By Application
    • 7.5.7.3. Market Size and Forecast, By End User
  • 7.5.8. South Africa Immunology Market
    • 7.5.8.1. Market Size and Forecast, By Product Type
    • 7.5.8.2. Market Size and Forecast, By Application
    • 7.5.8.3. Market Size and Forecast, By End User
  • 7.5.9. Rest of LAMEA Immunology Market
    • 7.5.9.1. Market Size and Forecast, By Product Type
    • 7.5.9.2. Market Size and Forecast, By Application
    • 7.5.9.3. Market Size and Forecast, By End User

CHAPTER 8: COMPETITIVE LANDSCAPE

• 8.1. Introduction
• 8.2. Top Winning Strategies
• 8.3. Product Mapping of Top 10 Player
• 8.4. Competitive Dashboard
• 8.5. Competitive Heatmap
• 8.6. Top Player Positioning, 2023

CHAPTER 9: COMPANY PROFILES

• 9.1. AbbVie Inc.
  • 9.1.1. Company Overview
  • 9.1.2. Key Executives
  • 9.1.3. Company Snapshot
  • 9.1.4. Operating Business Segments
  • 9.1.5. Product Portfolio
  • 9.1.6. Business Performance
  • 9.1.7. Key Strategic Moves and Developments
• 9.2. Johnson And Johnson
  • 9.2.1. Company Overview
  • 9.2.2. Key Executives
  • 9.2.3. Company Snapshot
  • 9.2.4. Operating Business Segments
  • 9.2.5. Product Portfolio
  • 9.2.6. Business Performance
  • 9.2.7. Key Strategic Moves and Developments
• 9.3. Pfizer Inc.
  • 9.3.1. Company Overview
  • 9.3.2. Key Executives
  • 9.3.3. Company Snapshot
  • 9.3.4. Operating Business Segments
  • 9.3.5. Product Portfolio
  • 9.3.6. Business Performance
  • 9.3.7. Key Strategic Moves and Developments
• 9.4. Novartis AG
  • 9.4.1. Company Overview
  • 9.4.2. Key Executives
  • 9.4.3. Company Snapshot
  • 9.4.4. Operating Business Segments
  • 9.4.5. Product Portfolio
  • 9.4.6. Business Performance
  • 9.4.7. Key Strategic Moves and Developments
• 9.5. Merck And Co., Inc.
  • 9.5.1. Company Overview
  • 9.5.2. Key Executives
  • 9.5.3. Company Snapshot
  • 9.5.4. Operating Business Segments
  • 9.5.5. Product Portfolio
  • 9.5.6. Business Performance
  • 9.5.7. Key Strategic Moves and Developments
• 9.6. Bristol-Myers Squibb Company
  • 9.6.1. Company Overview
  • 9.6.2. Key Executives
  • 9.6.3. Company Snapshot
  • 9.6.4. Operating Business Segments
  • 9.6.5. Product Portfolio
  • 9.6.6. Business Performance
  • 9.6.7. Key Strategic Moves and Developments
• 9.7. Amgen Inc.
  • 9.7.1. Company Overview
  • 9.7.2. Key Executives
  • 9.7.3. Company Snapshot
  • 9.7.4. Operating Business Segments
  • 9.7.5. Product Portfolio
  • 9.7.6. Business Performance
  • 9.7.7. Key Strategic Moves and Developments
• 9.8. Eli Lilly And Company
  • 9.8.1. Company Overview
  • 9.8.2. Key Executives
  • 9.8.3. Company Snapshot
  • 9.8.4. Operating Business Segments
  • 9.8.5. Product Portfolio
  • 9.8.6. Business Performance
  • 9.8.7. Key Strategic Moves and Developments
• 9.9. Gilead Sciences, Inc.
  • 9.9.1. Company Overview
  • 9.9.2. Key Executives
  • 9.9.3. Company Snapshot
  • 9.9.4. Operating Business Segments
  • 9.9.5. Product Portfolio
  • 9.9.6. Business Performance
  • 9.9.7. Key Strategic Moves and Developments
• 9.10. Sanofi
  • 9.10.1. Company Overview
  • 9.10.2. Key Executives
  • 9.10.3. Company Snapshot
  • 9.10.4. Operating Business Segments
  • 9.10.5. Product Portfolio
  • 9.10.6. Business Performance
  • 9.10.7. Key Strategic Moves and Developments